Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

G. Lelli · SciRah

Researcher profile · Semantic Scholar

G. Lelli

Share profile

G. Lelli — researcher profile on SciRah

h-index: 17
Works: 79
Citations: 1,256

Most-cited papers

A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours.
J. Pico, G. Rosti, A. Kramar, H. Wandt +13 more
2005Annals of Oncology265 citations Open access
Semantic Scholar
Correlation of adverse effects of cisplatin administration in patients affected by solid tumours: A retrospective evaluation
L. Astolfi, S. Ghiselli, V. Guaran, Milvia Chicca +4 more
2013Oncology Report214 citations Open access
Semantic Scholar
Effect of age and single versus multiple dose pharmacokinetics of letrozole (Femara®) in breast cancer patients
Christian Pfister, A. Martoni, Carlo Zamagni, G. Lelli +4 more
2001Biopharmaceutics & drug disposition100 citations
Semantic Scholar
Transitional cell carcinoma of the upper urinary tract: evaluation of prognostic factors by histopathology and flow cytometric analysis.
Francesco Corrado, C. Ferri, D. Mannini, Giuseppe Corrado +5 more
1991Journal of Urology70 citations
Semantic Scholar
Association of CYP1B1 with hypersensitivity induced by Taxane therapy in breast cancer patients
R. Rizzo, F. Spaggiari, M. Indelli, G. Lelli +3 more
2010Breast Cancer Research and Treatment69 citations Open access
Semantic Scholar
Prospective Phase II Study of Single-Agent Gemcitabine in Untreated Elderly Patients With Stage IIIB/IV Non–Small-Cell Lung Cancer
A. Martoni, F. di Fabio, M. Guaraldi, E. Piana +7 more
2001American Journal of Clinical Oncology46 citations
Semantic Scholar
Capecitabine plus oxaliplatin (xelox) versus protracted 5-fluorouracil venous infusion plus oxaliplatin (pvifox) as first-line treatment in advanced colorectal cancer: a GOAM phase II randomised study (FOCA trial).
A. Martoni, C. Pinto, F. di Fabio, G. Lelli +6 more
2006European Journal of Cancer43 citations
Semantic Scholar
A randomized phase II study of combination, alternating and sequential regimens of doxorubicin and docetaxel as first-line chemotherapy for women with metastatic breast cancer.
S. Cresta, G. Grasselli, M. Mansutti, A. Martoni +12 more
2004Annals of Oncology38 citations Open access
Semantic Scholar
Multicenter randomized clinical trial on high-dose epirubicin plus cis-platinum versus vinorelbine plus cis-platinum in advanced non small cell lung cancer.
A. Martoni, M. Guaraldi, E. Piana, E. Strocchi +15 more
1998Lung Cancer35 citations
Semantic Scholar
Pattern of care and effectiveness of treatment for glioblastoma patients in the real world: Results from a prospective population-based registry. Could survival differ in a high-volume center?
A. Brandes, E. Franceschi, M. Ermani, A. Tosoni +159 more
2014Neuro-Oncology Practice34 citations Open access
Semantic Scholar
Depression and serotonin transporter (5-HTTLPR) polymorphism in breast cancer patients.
L. Grassi, Elena Rossi, M. Cobianchi, Letizia Aguiari +7 more
2010Journal of Affective Disorders25 citations
Semantic Scholar
Treatment of the Cancer Anorexia-Cachexia Syndrome: A Critical Reappraisal
G. Lelli, M. Montanari, G. Gilli, D. Scapoli +1 more
2003Journal of chemotherapy25 citations
Semantic Scholar
Benign multicystic peritoneal mesothelioma: case reports and review of the literature
J. Giuliani, M. Marzola, Benedetta Urbini, M. Indelli +6 more
201024 citations
Semantic Scholar
Standard interleukin-2 (IL-2) and interferon-alpha immunotherapy versus an IL-2 and 4-epirubicin immuno-chemotherapeutic association in metastatic renal cell carcinoma.
E. Naglieri, V. Gebbia, E. Durini, G. Lelli +4 more
1998Anticancer Research20 citations
Semantic Scholar
The anabolic effect of high dose medroxyprogesterone acetate in oncology.
G. Lelli, B. Angelelli, M. Giambiasi, F. Colalongo +4 more
1983Pharmacological Research Communications20 citations
Semantic Scholar
Effect of the COVID-19 pandemic on surgery for indeterminate thyroid nodules (THYCOVID): a retrospective, international, multicentre, cross-sectional study
F. Medas, C. Dobrinja, E. Al-Suhaimi, J. Altmeier +495 more
2023The Lancet Diabetes and Endocrinology18 citations Open access
Semantic Scholar
Interleukin-2, interferon-alpha and medroxyprogesterone acetate in metastatic renal cell carcinoma.
E. Naglieri, Massimo Lopez, G. Lelli, F. Morelli +10 more
2002Anticancer Research18 citations
Semantic Scholar
Gastrointestinal Stromal Tumors and Other Malignancies: a Case Series
J. Giuliani, M. Marzola, M. Indelli, C. Aliberti +4 more
2012Journal of Gastrointestinal Cancer16 citations
Semantic Scholar
Differences in the Availability of New Anti-Cancer Drugs for Italian Patients Treated in Different Regions. Results of Analysis Conducted by the Italian Society of Medical Oncology (AIOM)
S. Gori, M. di Maio, C. Pinto, O. Alabiso +21 more
2010Tumori15 citations
Semantic Scholar
Randomized, Controlled, Multicenter Phase III Trial of Standard-Dose Fluorouracil-Epirubicin- Cyclophosphamide (FEC), Compared with Time-Intensive FEC (FEC-G) and Mitoxantrone-Methotrexate-Mitomycin C (MMM-G) in Metastatic Breast Carcinoma
A. Capotorto, L. Pavesi, P. Pedrazzoli, G. A. Da Prada +6 more
2003Journal of chemotherapy14 citations
Semantic Scholar
5‐Fluorouracil and levofolinic acid with or without recombinant interferon‐2b in patients with advanced colorectal carcinoma
G. Colucci, E. Maiello, V. Gebbia, F. Giuliani +6 more
1999Cancer13 citations Open access
Semantic Scholar
The antiemetic efficacy and the cost-benefit ratio of ondansetron calculated with a new approach to health technology assessment (real cost-benefit index).
S. Tanneberger, G. Lelli, A. Martoni, E. Piana +1 more
1992Journal of chemotherapy13 citations
Semantic Scholar
Multimodal treatment with primary single-agent epirubicin in operable breast cancer: 5-year experience of the Michelangelo Cooperative Group.
G. Bonadonna, M. Zambetti, C. Bumma, M. Donadio +7 more
2002Annals of Oncology9 citations Open access
Semantic Scholar
[Clear cell sarcoma of soft tissues. Clinico-pathological and ultrastructural analysis of a case in the head-neck region and a literature review].
Michele Bisceglia, I. Carosi, G. Lelli, Gianandrea Pasquinelli +1 more
1998Pathologica9 citations
Semantic Scholar
Hybrid (intravenous and oral) administration of vinorelbine plus cisplatinum followed by oral vinorelbine as first-line therapy of advanced non-small cell lung cancer: a phase II study.
A. Martoni, B. Melotti, F. Sperandi, S. Giaquinta +4 more
2008Lung Cancer8 citations
Semantic Scholar
Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset.
J. Thaler, R. Greil, Johannes Gaenzer, W. Eisterer +318 more
2015Annals of Oncology7 citations Open access
Semantic Scholar
Phase II randomized trial on protracted 5-fluorouracil infusion plus oxaliplatin (FOX) versus capecitabine plus oxaliplatin (XELOX) as first-line treatment in advanced colorectal cancer (ACRC): Preliminary results of the Italian FOCA Study
A. Martoni, C. Pinto, F. di Fabio, G. Lelli +6 more
20057 citations
Semantic Scholar
The Role of Cetuximab in Pre-Treated Refractory Patients with Metastatic Colorectal Cancer: Outcome Study in Clinical Practice
G. Lelli, S. Cataldo, I. Carandina, Benedetta Urbini +14 more
2008Journal of chemotherapy6 citations
Semantic Scholar
The effect of high dose medroxyprogesterone acetate on water and salt metabolism in advanced cancer patients.
G. Lelli, Bruna Angelelli, L. Zanichelli, E. Strocchi +4 more
1984Chemioterapia : international journal of the Mediterranean Society of Chemotherapy6 citations
Semantic Scholar
High-dose cyclophosphamide versus cyclophosphamide, methotrexate, 5-FU, and hydroxyurea (CMFH) in the treatment of stage III non-small cell bronchogenic carcinoma: a randomized trial.
F. Pannuti, G. Lelli, M. Casadio, E. Piana +1 more
1980Cancer treatment reports6 citations
Semantic Scholar
Salvage Treatment with Epirubicin and/or Paclitaxel in Metastatic Breast Cancer Patients Relapsed after High-dose Chemotherapy with Peripheral Blood Progenitor Cells
A. Tartarone, Z. Sirotovà, M. Aieta, G. Lelli
2001Tumori5 citations
Semantic Scholar
Epirubicin, folinic acid, fluorouracil, and etoposide in the treatment of advanced gastric cancer: phase II study of the Southern Italy Oncology Group (GOIM).
G. Colucci, Francesco Giuliani, V. Gebbia, A. Testa +6 more
1999American Journal of Clinical Oncology5 citations
Semantic Scholar
Combined chemo-immuno-hormonotherapy of advanced renal cell carcinoma.
A. Panetta, A. Martoni, M. Guaraldi, S. Tamberi +3 more
1994Journal of chemotherapy5 citations
Semantic Scholar
Is ondansetron "too expensive"?
F. Pannuti, Stephen Tanneberger, G. Lelli, E. Piana
1992The Lancet5 citations
Semantic Scholar
Impact of intervention aimed at improving the integration of oncology units and local palliative care services: results of the multicentre prospective sequential MIRTO study
A. Martoni, B. Melotti, Claudia Degli Esposti, V. Mutri +5 more
2017ESMO Open4 citations Open access
Semantic Scholar
A New Regimen of Cisplatin, Epirubicin and Methotrexate (PEM-3) as Primary Chemothfrapy for Locally Advanced Bladder Cancer
N. Cacciari, A. Martoni, A. Rossi, P. Turci +12 more
1996Tumori4 citations
Semantic Scholar
Cisplatinum plus epirubicin alternated with cyclophosphamide plus 5-fluorouracil in ovarian cancer.
A. Martoni, L. Ercolino, Antonia Bellucco, N. Canova +2 more
1990Journal of chemotherapy4 citations
Semantic Scholar
Incidence of neuroepithelial primary brain tumors among adult population of Emilia-Romagna Region, Italy
E. Baldin, S. Testoni, S. De Pasqua, S. Ferro +139 more
2017Neurological Sciences3 citations Open access
Semantic Scholar
The influence of externalized Groshong catheters or subcutaneously implanted ports on normal daily activities of cancer patients
G. Romano, A. Tartarone, R. Ardito, A. Bochicchio +6 more
20053 citations
Semantic Scholar
Mesenteric Fibromatosis in a Patient with Camurati-Engelmann Disease. A Case Report and Literature Review
P. Ballardini, L. Gulmini, G. Margutti, G. Lelli
2005Tumori3 citations
Semantic Scholar
Chemotherapy with cisplatin, epirubicin, methotrexate in the treatment of locally advanced or metastatic transitional cell cancer of the bladder (TCC).
G. Lelli, B. Melotti, F. Pannuti, A. P. Rossi +12 more
1992Journal of chemotherapy3 citations
Semantic Scholar
A phase II study on lonidamine combined with cisplatin and etoposide in the treatment of advanced non-small cell bronchogenic carcinoma (NSCBC).
G. Lelli, M. Guaraldi, N. Canova, M. Casadio +1 more
1990Journal of chemotherapy3 citations
Semantic Scholar
[High-dose chemotherapy of metastatic breast carcinoma].
A. Tartarone, M. Aieta, M. Morritti, G. Palomba +2 more
1998Clinica Terapeutica2 citations
Semantic Scholar
4'-Epidoxorubicin plus cisplatin as first-line therapy in the treatment of small cell bronchogenic carcinoma.
G. Lelli, M. Casadio, S. Giordani, C. Giuliotti +3 more
1987Chemioterapia : international journal of the Mediterranean Society of Chemotherapy2 citations
Semantic Scholar
Phase II studies on weekly cisplatinum plus epirubicin or etoposide in the treatment of advanced non-small cell bronchogenic carcinoma.
G. Lelli, M. Casadio, C. Giuliotti, S. Giordani +3 more
1986Chemioterapia : international journal of the Mediterranean Society of Chemotherapy2 citations
Semantic Scholar
Prevention of high dose melphalan-induced mucositis by cryotherapy in transplanted patients.
A. Tartarone, G. Romano, A. Bochicchio, A. Capobianco +6 more
2004Journal of Clinical Oncology1 citations
Semantic Scholar
[Clinical postoperative surveillance of breast carcinoma].
G. Lelli, M. Indelli, C. Modonesi, L. Gulmini +1 more
2002Recenti progressi in medicina1 citations
Semantic Scholar
[Primary tumors of the central nervous system: histogenetic classification, grade of malignity, clinico-pathologic features, and therapeutic criteria].
M. Bisceglia, V. d'Angelo, S. Parisi, G. Lelli +3 more
2000Pathologica1 citations
Semantic Scholar
Phase I - II study of oral idarubicin, tegafur and levo-folinate in patients with pretreated advanced breast cancer.
G. Cilenti, L. Tozzi, A. Suriano, A. Tartarone +1 more
1999Journal of chemotherapy1 citations
Semantic Scholar
Single and multiple dose pharmacokinetics of letrozole (® Femara) in elderly and younger postmenopausal patients (pts) with advanced breast cancer
C. Zamagni, A. Martoni, G. Lelli, F. D. de Braud +7 more
19991 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Martoni×11
Invite
A. Martoni — researcher profile on SciRah
F. Pannuti×11
Invite
F. Pannuti — researcher profile on SciRah
E. Piana×9
Invite
E. Piana — researcher profile on SciRah
A. Martoni×6
Invite
A. Martoni — researcher profile on SciRah

×5

Invite

E. Strocchi — researcher profile on SciRah

Invite

M. Casadio — researcher profile on SciRah

A. Tartarone×5

Invite

A. Tartarone — researcher profile on SciRah

Invite

M. Indelli — researcher profile on SciRah

Invite

F. di Fabio — researcher profile on SciRah

Invite

M. Guaraldi — researcher profile on SciRah

Invite

A. Brandes — researcher profile on SciRah

Invite

F. Albani — researcher profile on SciRah